Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Phase III IMpower150 study showed Roche’s TECENTRIQ (atezolizumab) and Avastin (bevacizumab) plus carboplatin and paclitaxel helped people with advanced lung cancer live longer compared to Avastin plus carboplatin and paclitaxel
Phase III IMpower150 study showed Roche’s TECENTRIQ (atezolizumab) and Avastin (bevacizumab) plus carboplatin and paclitaxel helped people with advanced lung cancer live longer compared to Avastin plus carboplatin and paclitaxel
Roche (SIX.
Drug compound shows promise against rheumatoid arthritis
Drug compound shows promise against rheumatoid arthritis
Scientists have designed a new drug compound that dials down inflammation, suggesting possible future uses against autoimmune disorders such as rheumatoid arthritis.
Drugmaker Shire soars as Japan's Takeda considers bid
Drugmaker Shire soars as Japan's Takeda considers bid
LONDON/TOKYO (Reuters) - Japan’s largest drugmaker Takeda Pharmaceutical (4502.
New drug significantly reduces smoking habit in heart attack patients
New drug significantly reduces smoking habit in heart attack patients
Patients who smoke after an acute coronary syndrome, including a heart attack (myocardial infarction) or unstable angina (reduced blood flow to the heart) are at increased risk of anot...
Alzheimer's solution that requires 'no prescription or doctor': Painkiller ibuprofen could 'eliminate' the disease, reveal scientists
Alzheimer's solution that requires 'no prescription or doctor': Painkiller ibuprofen could 'eliminate' the disease, reveal scientists
Ibuprofen could prevent Alzheimer's disease, scientists claim.
Newly-discovered human organ may help explain how cancer spreads
Newly-discovered human organ may help explain how cancer spreads
A newly discovered network of fluid-filled channels in the human body may be a previously-unknown organ, and it seems to help transport cancer cells around the body.
Scientists Use Synthesized Antibiotic to Treat Bacterial Infection in Mice for the First Time
Scientists Use Synthesized Antibiotic to Treat Bacterial Infection in Mice for the First Time
In 2015, scientists discovered a new antibiotic called teixobactin.
Biohaven shares drop 23% after migraine drug trial results
Biohaven shares drop 23% after migraine drug trial results
Biohaven Pharmaceutical Holding Co.
300 million hepatitis B sufferers but only one in 20 treated: study
300 million hepatitis B sufferers but only one in 20 treated: study
Some 300 million people worldwide are living with the deadly hepatitis B virus (HBV), but only one in 20 received adequate treatment, researchers reported Tuesday.
GSK reaches agreement with Novartis to acquire full ownership of Consumer Healthcare Business
GSK reaches agreement with Novartis to acquire full ownership of Consumer Healthcare Business
GlaxoSmithKline plc (LSE/NYSE.
Arena Pharmaceuticals Reports Positive Phase 2 Results from the OASIS Trial for Etrasimod in Patients with Ulcerative Colitis
Arena Pharmaceuticals Reports Positive Phase 2 Results from the OASIS Trial for Etrasimod in Patients with Ulcerative Colitis
SAN DIEGO, March 19, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc.
GSK pulls out of $20 billion race for Pfizer consumer assets
GSK pulls out of $20 billion race for Pfizer consumer assets
LONDON (Reuters) - GlaxoSmithKline (GSK.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand